Is Pfizer Stock a Buy?
's (NYSE: PFE) share price has fallen more than the S 500 so far this year. The big pharma stock is nearly 60% below its high set in late 2022. By most standards, Pfizer looks like the proverbial knife in the investing adage, "Don't try to catch a falling knife."
But could Pfizer stock be a smart pick to buy right now? I think there's more than one answer.
If you're a growth investor, you probably won't be interested in buying Pfizer stock. And I don't make that assumption based on Pfizer's abysmal performance in recent years. The reality is that the drugmaker faces serious headwinds in the near future, too.
Source Fool.com
Pfizer Inc. Aktie
21,42 €
0,30 %
Die Pfizer Inc. Aktie erhält eine Reihe von Buy-Einschätzungen, die die Sell-Zahlen übertreffen.
Das von der Community festgelegte Kursziel von 27 € für Pfizer Inc. bedeutet eine mögliche Steigerung um über 20% im Vergleich zu 21.42 €.
